Teva Wins $176M From Eli Lilly In Migraine Drug Patent Trial
A Boston federal jury on Wednesday ordered Eli Lilly & Co. to pay $176.5 million to Teva Pharmaceuticals after finding that its migraine drug Emgality willfully infringed three Teva patents....To view the full article, register now.
Already a subscriber? Click here to view full article